These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20568097)

  • 1. Evidence-based apheresis makes the GRADE.
    Weinstein R
    J Clin Apher; 2010; 25(3):81-2. PubMed ID: 20568097
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.
    Szczepiorkowski ZM; Winters JL; Bandarenko N; Kim HC; Linenberger ML; Marques MB; Sarode R; Schwartz J; Weinstein R; Shaz BH;
    J Clin Apher; 2010; 25(3):83-177. PubMed ID: 20568098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apheresis medicine state of the art in 2010: American Society for Apheresis fifth special edition of the Journal of Clinical Apheresis.
    Winters JL
    J Clin Apher; 2011; 26(5):239-42. PubMed ID: 21882234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How we developed and use the American Society for Apheresis guidelines for therapeutic apheresis procedures.
    Shaz BH; Schwartz J; Winters JL
    Transfusion; 2014 Jan; 54(1):17-25. PubMed ID: 24261606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue.
    Schwartz J; Winters JL; Padmanabhan A; Balogun RA; Delaney M; Linenberger ML; Szczepiorkowski ZM; Williams ME; Wu Y; Shaz BH
    J Clin Apher; 2013 Jul; 28(3):145-284. PubMed ID: 23868759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Society for Apheresis guidelines on the use of apheresis in clinical practice: practical, concise, evidence-based recommendations for the apheresis practitioner.
    Winters JL;
    J Clin Apher; 2014 Aug; 29(4):191-3. PubMed ID: 24890667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How we approach an apheresis request for a Category III, Category IV, or noncategorized indication.
    Shaz BH; Winters JL; Bandarenko N; Szczepiorkowski ZM
    Transfusion; 2007 Nov; 47(11):1963-71. PubMed ID: 17958524
    [No Abstract]   [Full Text] [Related]  

  • 8. Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.
    Szczepiorkowski ZM; Bandarenko N; Kim HC; Linenberger ML; Marques MB; Sarode R; Schwartz J; Shaz BH; Weinstein R; Wirk A; Winters JL; ;
    J Clin Apher; 2007 Jun; 22(3):106-75. PubMed ID: 17394188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internet-based quality assurance registry for LDL apheresis QUASA--the apheresis registry.
    Dräger J; Petzold S; Ristau H; Trepte S
    Transfus Apher Sci; 2005 Oct; 33(2):81-5. PubMed ID: 16137926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma exchange: concepts, mechanisms, and an overview of the American Society for Apheresis guidelines.
    Winters JL
    Hematology Am Soc Hematol Educ Program; 2012; 2012():7-12. PubMed ID: 23233554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Apheresis in inflammatory bowel disease].
    Nos P; Domènech E
    Gastroenterol Hepatol; 2009; 32(7):509-18. PubMed ID: 19608298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailored collection of multicomponent by apheresis.
    Blanco L
    Transfus Apher Sci; 2002 Oct; 27(2):123-7. PubMed ID: 12350047
    [No Abstract]   [Full Text] [Related]  

  • 13. Critical updates in the 7
    Ipe TS; Pham HP; Williams LA
    J Clin Apher; 2018 Feb; 33(1):78-94. PubMed ID: 28653762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LDL apheresis in Italy.
    Iacone A
    Transfus Apher Sci; 2007 Dec; 37(3):211-2. PubMed ID: 18042439
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of clinical practice guidelines on the clinical microbiology laboratory when using automated blood culture systems for bacterial contamination screening of apheresis platelet products.
    Stutzman LC; Sullivan N
    J Clin Microbiol; 2004 Dec; 42(12):5963; author reply 5963-4. PubMed ID: 15583355
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of blood donors with a low level of exposure to vCJD.
    Pasqualetti D; Ghirardini A; Bellocco R; Vaglio S; Gozzer M; Girelli G
    Haematologica; 2001 Mar; 86(3):E04. PubMed ID: 11255291
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficient and safe stem cell apheresis.
    Ohto H
    Transfus Apher Sci; 2004 Dec; 31(3):203-5. PubMed ID: 15556468
    [No Abstract]   [Full Text] [Related]  

  • 18. [Appropriate method of apheresis in Guillain-Barré syndrome].
    Ito H; Saito T; Sakai F
    Rinsho Shinkeigaku; 1999 Nov; 39(11):1168-70. PubMed ID: 10689945
    [No Abstract]   [Full Text] [Related]  

  • 19. Validation of training and competency of apheresis specialists: organizational guidelines for therapeutic apheresis facilities.
    J Clin Apher; 1998; 13(4):174-89. PubMed ID: 9886797
    [No Abstract]   [Full Text] [Related]  

  • 20. Category IV indications for therapeutic apheresis: ASFA fourth special issue.
    Shaz BH; Linenberger ML; Bandarenko N; Winters JL; Kim HC; Marques MB; Sarode R; Schwartz J; Weinstein R; Wirk A; Szczepiorkowski ZM
    J Clin Apher; 2007 Jun; 22(3):176-80. PubMed ID: 17377982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.